ABSTRACT. The compromised human newborn frequently presents with overwhelming feeding problems which lead to inadequate intake. These problems may affect the development of the small intestine, especially mucosal barrier function, leading to increased infections and susceptibility to allergens. To study this, an animal model was established using neonatal rabbits deprived of nutrients from birth until 72 h. Mucosal barrier function was compared in deprived and control (naturally fed 72-hold animals) rabbits by measuring immunoreactive bovine serum albumin in serum 4 h after intragastric infusion of crystalline bovine serum albumin (200 mg/100 g body weight). Trypsin activity was measured in rinse fluid obtained from the small intestine. Representative sections of jejunum from control and experimental animals were formalin fixed and stained with hematoxylin and eosin for morphologic comparison. Following the bovine serum albumin feeding, a significantly increased serum immunoreactive bovine serum albumin and significantly decreased trypsin-like activity of the small intestinal rinse fluid was noted in starved animals compared to controls. In addition, the enterocytes of malnourished animals were more cuboidal and contained fewer and smaller supranuclear granules on microscopic examination than the enterocytes of controls. This study suggests that short-term starvation in newborns affects mucosal barrier function. Acute starvation may place newborns at increased risk for infections and allergic disease.
Aims
Proposed ESPGHAN guidelines recommend that coeliac disease can be diagnosed in patients with a positive history of suggestive symptoms, positive serology markers for coeliac disease and a response to a gluten-free diet without the need for a duodenal biopsy. In contrast, current NICE guidelines advise that a biopsy showing histological features compatible with coeliac disease is required for a diagnosis.
This study examined whether using NICE guidelines versus using proposed ESPGHAN guidelines is likely to prevent unnecessary upper GI endoscopy and biopsy in a substantial number of children.
Methods
A retrospective cohort of 70 children with positive serology for coeliac disease who underwent upper intestinal biopsy were investigated. Results of serology testing and histopathology findings discussed at clinicopathological conference were examined.
Results
Of the 70 patients, 43 were positive for autoantibodies to both endomysial (EMA) and tissue transglutaminase (tTG). All of the children strongly positive for both markers had a biopsy suggestive of coeliac disease.
Overall, 64 (91%) of children who underwent endoscopy had histopathological findings compatible with coeliac disease. Two patients with (weakly) positive serology to both markers had a negative biopsy for coeliac disease. One of these patients had a background of Down syndrome and the other was later diagnosed with fructose intolerance. Three children with negative biopsies were EMA positive but tTG negative. One patient with a biopsy that was not suggestive of coeliac disease was EMA negative and tTG positive. This child went on to show improvement with a gluten-free diet.
Conclusion
This small study examined children with positive serological markers for coeliac disease who under NICE guidelines warranted upper GI endoscopy and biopsy. Over 90% showed histopathological findings that were compatible with coeliac disease and all of those children that were strongly positive for tTg and EMA had a positive biopsy and went on to respond to a gluten-free diet. This data suggests that children with symptoms suggestive of coeliac disease and with strongly positive serology can be commenced on a gluten-free diet without the need for duodenal biopsy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.